Access cutting-edge obesity in pregnancy treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Oklahoma City location
Preparing your pre-screening questions…
Access obesity in pregnancy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity in pregnancy treatment provided free
Check if you qualify for this obesity in pregnancy clinical trial in Oklahoma City, OK
No-Cost Study Care
Local to Oklahoma City
Convenient for OK residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Obesity increases the risk of pregnancy complications, including puerperal infections and cesarean delivery, and risk rises with increasing body mass index (BMI). Since obese women are more likely to have comorbidities that would necessitate delivery prior to their due date (i.e. prior to 40 weeks gestation), and class III obesity specifically is an indication for delivery by 39 weeks, these patients have a high rate of labor induction. In nulliparous women from the general population (obese and non-obese), labor induction at 39 weeks (compared to expectant management) is associated with less maternal morbidity and a lower cesarean rate. Researchers previously conducted a pilot randomized placebo-controlled trial in obese, nulliparous women undergoing labor induction at term and found that the cesarean delivery rate was lower in women who received a prophylactic antibiotic regimen during labor compared with those who received the placebo. Researchers proposed multi-center trial aims to test this hypothesis in a large sample with adequate power to determine whether prophylactic antibiotics during labor are associated with a decrease in the rate of cesarean delivery in term, nulliparous, obese women. If the findings from the pilot trial are confirmed, this would represent a novel intervention to decrease the cesarean delivery rate in a subset of women at highest risk for cesarean-related complications.
Sponsor: University of Oklahoma
Yes, this clinical trial (NCT06488781) has an active research site in Oklahoma City, OK that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for obesity in pregnancy treatment options in Oklahoma City, OK, this clinical trial (NCT06488781) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity in pregnancy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all obesity in pregnancy clinical trials near you to find additional studies recruiting in your area.
See all obesity clinical trials recruiting in Oklahoma City — not just this study.
Browse Obesity Trials in Oklahoma City →